Trial Profile
A Phase 2, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of TSN2898 Topical Gel for the Treatment of Acne Vulgaris
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 28 Apr 2017
Price :
$35
*
At a glance
- Drugs TSN 2898 (Primary)
- Indications Acne vulgaris
- Focus Adverse reactions
- Sponsors Thesan Pharmaceuticals
- 24 Apr 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 05 Jul 2016 New trial record